DOCSLIB.ORG

Anabolic Steroids Detected in Bodybuilding Dietary Supplements– a Significant Risk to Public Health V

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Anabolic Steroids Detected in Bodybuilding Dietary Supplements– a Significant Risk to Public Health V Drug Testing 1esearch article and Analysis Received; ,. June ,01$ Revised; 1 September ,01$ <ccepted: $ September ,01$ =ublished online in 7iley Online Library 3!!!.drugtestinganalysis.com4 >%I 1..1..,?dta.17,@ Anabolic steroids detected in bodybuilding dietary supplements– a significant risk to public health V. Abbate,a A. T. Kicman,b M. Evans-Brown,c J. McVeigh,d D. A. #owan,b #. Wilson,e S. J. #olese and C. J. $alkerb& Twenty-four products suspected of containing anabolic steroids and sold in fitness equipment shops in the (nited Kingdom )(K) ere analyzed for their qualitative and semi-quantitative content using full scan gas chromatography-mass spectrometry ),#-M%*, accurate mass li'uid chromatography-mass spectrometry )-#-M%*, high pressure liquid chromatography ith diode array detection )./-#-"A"*, (V-Vis, and nuclear magnetic resonance )0M1* spectroscopy. 2n addition, 3-ray crystallography enabled the identification of one of the compounds, here reference standard as not available. 4f the 56 products tested, 57 contained steroids including kno n anabolic agents8 9: of these contained steroids that ere different to those indicated on the packaging and one product contained no steroid at all. 4verall, 97 different steroids ere identified8 95 of these are controlled in the (K under the Misuse of "rugs Act 9;<9. %everal of the products contained steroids that may be considered to have considerable pharmaco- logical activity, based on their chemical structures and the amounts present. This could un ittingly e=pose users to a significant risk to their health, hich is of particular concern for na>ve users. #opyright ? 5@96 !ohn $iley A %ons, -td. Additional supporting information may be found in the online version of this article at publisher’s web site. Key ords: anabolic steroids; dietary supplements; image-enhancing drugs; X-ray crystallography; hepatotoxicity; performance-enhancing drugs 2ntroduction Most of the anabolic steroids used in these products are pro- duced in bulk and obtained from wherever they can be cheaply In recent years, a large global uncontrolled market in human and reliably sourced, imported into countries such as the &nited enhancement drugs has developed.[1] This market is a result of States and the United Kingdom where they are processed and entrepreneurs exploiting demand from consumers, and is tightly packaged into finished products and sold in bricks-and-mortar coupled to increased manufacturing capacity of pharmacologically and online fitness equipment shops; their sale as‘dietary supple- active substances in countries with emerging economies, global- ments’ appears to be a ploy to circumvent regulatory systems such ized free trade, and modern communication and transport as those governing medicines. Consumers may find such products networks. Consumers looking to get a better body, empower them- attractive given the marketing practices used by manufacturers and selves and increase their well-being can no! choose from a broad distributors, as well as their ease of availability. %f particular concern range of drugs that claim to allow them to lose weight, brighten here is that potentially vulnerable groups such as teenage boys as their mood, modify their social and sexual behaviour, lighten or well as young men who face gro!ing pressures to conform to a tan their skin, enhance their cognitive function, and build muscle.[1] more stylized muscular body image,[23] may also use such In order to boost sales of these drugs, entrepreneurs have used a products; such a scenario has been seen before in the &nited States range of creative and apparently persuasive marketing strategies,[1] including the sale of these drugs as off-the-shelf‘dietary’,‘food’, or ‘herbal’ ‘supplements’.[1–4] One example of this practice in the &nited Kingdom is the sale of such drugs as bodybuilding‘dietary * Correspondence to: Chris Walker, Drug Control Centre, King’s College London, supplements’ which are often marketed as‘safer’ and‘legal’ !ranklin-Wilkins Building, $%& Stamford Street, London '($ )*H, ,K. ("mail: [email protected] replacements to established anabolic steroids and other [1] performance-enhancing drugs. Similar to the‘legal highs’ a Institute of /harmaceutical Science, King’s College London, Franklin-Wilkins phenomenon,[5,6] and to some degree overlapping,[7–1,] this Building, $%& Stamford Street, London '($ )*H, UK market has been driven by opportunists[13] who have searched b Drug Control Centre, King’s College London, Franklin-Wilkins Building, $%& the scientific and patent literature for active substances, which !ere Stamford Street, London '($ )*H, UK often originally synthesized as part of academic and pharmaceuti- cal research programmes but were not commercialized as c European Monitoring Centre for Drugs and Drug Addiction, Lisbon, /ortugal medicines.[14–,.] Importantly, when such products containing anabolic steroids first emerged in the mid to late 1//.s in the d Centre for Public +ealth, iverpool John Moores University, Liverpool, 2 3(4, UK &nited States, the substances were also selected on the basis that e (/'5C ,K National Crystallography Service, School of Chemistry, University of [21,,,] they were not sub0ect to drug control laws at that time. Southampton, Southampton, '6$7 $#J, ,K Drug 4est. Analysis35@964 Copyright 5 ,.1$ 6ohn 7iley 8 (ons, 9td. Drug Testing and Analysis V. Abbate et al. when supplements containing androstenedione were available monitoring of online shops, bodybuilding !ebsites discussing these from high street and online shops during the late 19/.s and early products, as !ell as from members of the gym community familiar ,...s.[21,,$] The primary aim of the current investigation was to !ith the use of these products. In order to examine any potential identify the specific active substance(s) and estimate the dose pres- variation in composition bet!een different samples of the same ent in a series of bodybuilding‘dietary supplements’ that were product, four products bearing the same name as those purchased suspected to contain anabolic steroids. %ften publications have from the bricks-and-mortar retailers !ere also purchased via the predominantly focused on the accuracy of the container label with Internet, making a total of ,. different products that !ere analy"ed. regard to !hether that steroid is present, without verification of Potassium hydroxide 3'%B4, anhydrous sodium sulfate, sodium amount. Little, if anything, is known about the toxicity or efficacy chloride, ethyl acetate, chloroform and hexane, all analytical of many of these anabolic steroids but, !ith the presumption that reagent grade, and high-performance liquid chromatography they are biologically active on the basis of their structures, knowing 3B=9#4 grade methanol, dichloromethane, acetonitrile, and trifluo- the dose can give an insight into whether these products are likely roacetic acid were purchased from Cisher Scientific 3Loughborough, to be pharmacologically significant. &sing spectroscopic and &'). >odecane, deuterochloroform, D-methyl-N-trimethylsilyl- spectrometric approaches any steroid present in the supplements trifluoroacetamide 31( C<4, ethanethiol, androst-4-ene-3,1+-dione, was characterized and, when estimated to be present in more than adrenosterone (androst-4-ene--,11,1+-trione), dehydroepiandros- 1 mg, the amount also determined. terone 3>BE<4 and ammonium iodide 3DB$I) !ere purchased from Sigma-Aldrich 3Poole, &'4. Cormic acid Analar grade was purchased from F7: 39utterworth, &'4. Curazabol, desoxymethyltestosterone Materials and methods 3>1T, madol) and methasterone were obtained through the World Association of Anti->oping Scientists 37<<>(4 as part of its < total of ,$ products were purchased from two fitness equipment educational programme. =urified !ater was obtained from E9G< shops one in 1erseyside 3n=$ products4 and one in Cheshire (nA-4 Purelab 1axima 3Fivendi Water (ystems, High Wycombe, &'). , and three online shops (nA); n=*; n=*4 3 able 14. The products were Methyl-1-testosterone and [1/,1/,1/- B-]-testosterone (d- 4 was selected after a revie! of information collected from Internet purchased from 9G# =romochem 3 eddington, &'). Table 1. 9ist of the products analyzed with the name of the active ingredient, dose and recommended serving as listed on the packaging. 3H spelling errors in the nomenclature in addition to‘a’ and‘b’ used forα andβ4 I Product Name 1anufacturer?(upplier 9abelled Contents 9abelled >ose Recommended per tablet or serving of tablet capsule 3mg4 or capsule 1 (uper ren-1G Black #hina Labs 1--ethyl-3mthoxy-gona-2,53104 diene-1+-oneH ,) 1/day , 1/-Nor ren Tri-City #hemicals 1/-Norandrosta-4,9-diene--,1+-dione -) ,--/day - ren Bomb Pharma 9abs 1+b-hydoxy-androstan-$-oneH 1. ,/day $ (uper Balo Black #hina Labs polydehydrogenated, polyhydroxylated ,) 1/day halomethetioallocholane ) (traight Epi Black #hina Labs ,,3a-Epithio-1+a-methyletioallo cholane-1+b-ol 1. 1/day * (traight Drol Black #hina Labs 1+a-dimethyl-5a-androst-3-one-1+b-ol 1. 1/day + (traight Phlexed Black #hina Labs 1+a-methyletioallocholan-2-ene-1+b-ol 1. 1/day @ Protodrol I Force Dutrition Protodrol ,) ,/day / Cynostane AI ,-cyano-17a-methyl-1+b-hydroxy-androst---one 1. 1/day 1. Fura"adrol Axis 9abs )a-etioallocholan[,,--c]furazan-1+b- ). ,--/day tetrahydropyranol ether 11 renavol-F Chaparral Labs. Estra-$,9-diene--,1+-dione -. 1--/day 1, &ltra 1ass <=( 1/-Norandrosta-$,9-diene--,1+-dione $. ,--/day 1+a-methyletioallocholan-2-ene-1+b-ol 1. 1- 11-Sterone Competitive Edge 9abs. <ndrost-$-ene-3,11,1+-trione +) --*/day 1$ P-1<G Competitive Edge 9abs. $-Chloro-1+a-methyl-andro-4-ene--,1+b-diol ,) ,--/day 1) Furuza-A Competitive Edge 9abs. )a-etioallocholan[2,--c]furazan-1+b- ). ,--/day tetrahydropyranol ether 1* Epivol Chaparral Labs. Estra-$,9-diene--,1+-dione -. 1-,/day ,a,3a-Epithio-1+a-methyletioallocholanol 1. 1+ 1-L1G Competitive Edge 9abs. 1--ethyl-3methoxy-gona-2,5(1.4 diene-1+-one ,) ,--/day 1@ X- ren Competitive Edge 9abs. 1/-Norandrosta-4,9-diene--,1+-dione -. --*/day 1/ Epivol Jlack Black #hina Labs ,,3a-Epithio-1+a-methyl-)a-androstan-1+b-ol 1.
Load more

Recommended publications
  • Seco-Steroids C07C)
    CPC - C07J - 2021.08 C07J STEROIDS (seco-steroids C07C) Definition statement This place covers: Compounds containing a cyclopenta[a]hydrophenanthrene skeleton (see below) or a ring structure derived therefrom: • by contraction or expansion of one ring by one or two atoms; • by contraction or expansion of two rings each by one atom; • by contraction of one ring by one atom and expansion of one ring by one atom; • by substitution of one or two carbon atoms of the cyclopenta[a]hydrophenanthrene skeleton, which are not shared by rings, by hetero atoms, in combination with the above defined contraction or expansion or not, or; • by condensation with carbocyclic or heterocyclic rings in combination with one or more of the foregoing alterations or not. Preparation of steroids including purification, separation, stabilisation or use of additives unless provided for elsewhere, as specified below. Treatment and modification of steroids provided that • the treatment is not provided for elsewhere and • the resultant product is a compound under the subclass definition. Relationships with other classification places In class C07, in the absence of an indication to the contrary, a compound is classified in the last appropriate place, i.e. in the last appropriate subclass. For example cyclopenta [a] hydrophenantrenes are classified in subclass C07J as steroids and not in subclasses C07C or C07D as carbocyclic or heterocyclic compounds. Subclass C07J is a function-oriented entry for the compounds themselves and does not cover the application or use of the compounds under the subclass definition. For classifying such information other entries in the IPC exist, for example: Subclass A01N: Preservation of bodies of humans or animals or plants or parts thereof; biocides, e.g.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,585,591 Nitta Et Al
    United States Patent (19) 11 Patent Number: 4,585,591 Nitta et al. (45) Date of Patent: Apr. 29, 1986 (54) 17B-ETHYNYLSTEROIDs AND PROCESS 56) References Cited FOR PREPARNG SAME U.S. PATENT DOCUMENTS 75) Inventors: Issei Nitta, Machida; Shinichiro 3,023,206 2/1962 Burnet al. ..................... 260/239.55 Fujimori, Yokohama; Toshio Haruyama, Sagamihara; Shinya FOREIGN PATENT DOCUMENTS Inoue, Yamato, all of Japan 845441 8/1960 United Kingdom ............. 260/397.4 73 Assignee: Mitsubishi Chemical Industries, Ltd., OTHER PUBLICATIONS Tokyo, Japan L. A. van Dijck et al., "Synthesis and Reactions of 3-Methoxy-17-Hydroxy-17-Ethynyl-1,3,5(10)-Estra 21 Appl. No.: 325,026 triene', Recueil Journal of the Royal Netherlands Chemical Society, 96,7-8, Jul.-Aug., pp. 200-205 22 Filed: Nov. 25, 1981 (1977). Primary Examiner-Elbert L. Roberts 30 Foreign Application Priority Data Attorney, Agent, or Firm-Oblon, Fisher, Spivak, Dec. 10, 1980 JP Japan ................................ 55-174065 McClelland & Maier Dec. 10, 1980 JP Japan ... ... 55-174.066 Feb. 23, 1981 JP Japan .................................. 56-25307 (57) ABSTRACT Jul. 28, 1981 (JP) Japan ................................ 56-18343 This is disclosed novel intermediates, i.e. 1743-ethynyl steroids, which are useful for the preparation of corti 51) Int. Cl. .................................................. CO7J 1/00 coids such as hydrocortisone and prednisolone, and a 52 U.S. C. ............................ 260/3974; 260/397.45; process for preparing the same. 260/239.55 C, 260/397.5; 260/397.47 58) Field of Search ......................... 260/397.4, 397.45 4 Claims, No Drawings 4,585,591 1 2 17(3-ETHYNYLSTEROIDS AND PROCESS FOR -continued PREPARING SAME CECH BACKGROUND OF THE INVENTION This invention relates to a novel intermediate for use in the preparation of corticoids (adrenocortical hor mones) such as hydrocortisone, prednisolone and the MeO like.
    [Show full text]
  • Steroidogenic Pathway Poster-COMPLEX-24X36
    Cholesterol The Steroidogenic Pathways Congenital adrenal hyperplasia (CAH), Hyperglycemia, azole antifungals, aging, smoking, E2, progesterone, azole smoking, dioxin toxicity, HIV, licorice, Phytoestrogens, flaxseed, licorice, Alcohol, IL-6, abdominal obesity, DHEA, antifungals, spironolactone etomidate, liarozole progestins, tamoxifen forskolin (-) (-) (-) (+) Pregnenolone CYPc17 17-OH-Pregnenolone 17,20 Lyase DHEAA17βHSD ndrostenediol (+) Hyperglycemia, hyperinsulinemia, PCOS (ovary), stress, alcohol, antiepileptics (+) CAH, chronic ETOH ingestion, PCB toxicity, progestins, D D D (-) (-) D PCB toxicity, DHEA, antiepileptics isoflavonoids, metformin, troglitazone, trilostane HS Pregnanediol Pregnanetriol β HS HS 3 HS β β β 3 3 3 (+) Hyperadrenalism, hyperthyroidism, hyperinsulinemia, PCOS, IL-4 (+) and IL-13, IGF-1, forskolin Smoking, dioxin, isoflavones, flaxseed, procyanidins, flavonoids, EGCG, epilobium, vitamin C, anastrazole, etc; CYPc17 17,20 Lyase 17βHSD Progesterone 17-OH-Progesterone Androstenedione Testosterone chrysin, stinging nettles, (-) and other flavonoids; β 5 ketoconazole, metformin α (+) (+) 1 5 1 Sodium depletion, high prolactin More cortisol: Less cortisol: Etiocholanolone Obesity (esp. visceral), A Good insulin sensitivity, ro CAH, late-onset adrenal hyperplasia, primary adrenal CYP2 metabolic A CYP2 hyperthyroidism, ro 5 m Excess adipose, alcohol, zinc (-) insufficiency, ankylosing spondylitis, increased salt (-) syndrome, hypothyroid, m α DHT at reduced inflammation, atas a (+) deficiency, stress, cravings, resveratrol,
    [Show full text]
  • GC/C/IRMS) Als Potentielle Untersuchungsmethode Zum Nachweis Einer Illegalen Anwendung Von 19-17 Βββ-Nortestosteron in Der Ebermast
    Einsatz der Stabilisotopen-Massenspektrometrie (GC/C/IRMS) als potentielle Untersuchungsmethode zum Nachweis einer illegalen Anwendung von 19-17 βββ-Nortestosteron in der Ebermast Dissertation zur Erlangung des akademischen Doktorgrades der Naturwissenschaften an der Bergischen Universität im Fachbereich Mathematik und Naturwissenschaften Die Arbeit wurde in der Zeit vom 15. Mai 2003 bis 31.Dezember 2006 am Chemischen und Veterinäruntersuchungsamt in Freiburg angefertigt vorgelegt von Annette Mertineit-Heinz Wuppertal 2007 Diese Dissertation kann wie folgt zitiert werden: urn:nbn:de:hbz:468-20070870 [http://nbn-resolving.de/urn/resolver.pl?urn=urn%3Anbn%3Ade%3Ahbz%3A468-20070870] dem Allmächtigen Gott Das Geheimnis Gottes ist Jesus Christus, in dem alle Schätze der Weisheit und Erkenntnis verborgen sind. Die Bibel , Kolosser 2, 3 Dank Mein besonderer Dank gilt Herrn Prof. Dr. Michael Petz, der es mir ermöglichte, an der Universität Wuppertal diese Dissertation anzufertigen. Für seine Hilfsbereitschaft und Ermutigungen bin ich ihm sehr dankbar. Bedanken möchte ich mich beim Amtsleiter des CVUA Herrn Dr. Roland Renner sowie Laborleiter Herrn Dr. Martin Metschies, dass ich die Untersuchungen für diese Arbeit am CVUA durchführen durfte. Bei Laborleiterin Frau Dr. Eva Annweiler möchte ich mich für ihre vielseitige Unterstützung in analytischen Fragen und ihre Hilfe bei der Durchsicht der Arbeit bedanken. Den Labormitarbeitern Herrn Thomas Huber danke ich für die Unterstützung bei den EA/IRMS-Messungen, Frau Sylvia Scanlan-Sierra bei den GC/MS-Messung und Herrn Manfred Grosse bei den GC/FID-Messungen. Herr Grosse hat sich immer Zeit genommen, mich zu unterstützen, ohne dabei seine tägliche Arbeit zu vernach- lässigen. Für die Unterstützung der Aufarbeitung der Eberurine gilt mein Dank Laborleiter Herr Lippold und den Mitarbeitern Frau Annabarbara Fies, Herrn Markus Roth und Frau Maria Schmidt.
    [Show full text]
  • United States Patent Office Patented Jan
    3,231,567 United States Patent Office Patented Jan. 25, 1966 2 droxy ethylene, hydroxy propylene, hydroxybutylene and 3,231,567 PROCESS FOR THE PREPARATION OF 3-HY the like; a saturated or unsaturated cycloaliphatic moiety, DROXY. AND 3-ALKOXY-ESTRATRIENES such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, AND INTERMEDIATES THEREFOR cyclopentenyl, cyclohexenyl, cyclopentylpropyl, cyclo Alberto Ercoli and Rinaldo Gardi, Milan, and Cesare 5 heptyl, cyclooctyl radical; or an araliphatic moiety, such Pedrai, Bergamo, Italy, assignors to Francesco Wismara as benzyl, phenetyl, cynnamyl radical. Preferred hydro S.p.A., Casadenovo, Italy carbon radicals are aliphatic moieties containing from 1 No Drawing. Fied Dec. 16, 1963, Ser. No. 330,584 to 8 carbon atoms, inclusive, cycloaliphatic moieties con Claims priority, application Italy, Dec. 19, 1962, taining from 5 to 6 carbon atoms in the ring and the Patent 24,856/62 benzyl radical. 20 Claims. (C. 260-239.55) 10 Methods for the aromatization of the ring A of 19-nor This invention relates to an improved process for con steroids are already known in the literature and the prior verting steroids of the 19-nor-androstane and 19-nor-preg art teaches the conversion of a 3-keto-19-norsteroid of name series into derivatives of the estrogenic series. The the androstane series into a derivative of the estrogenic invention also relates to certain new 19-norsteroid deriva 5 series. This conversion may be accomplished by first tives useful as intermediates in said conversion. preparing a 5,10-epoxy-estren-3-one or a 3-ketal thereof More particularly, this invention is concerned with a by epoxiding a 5 (10)-estrene-3-one or A-3-keto-19-nor amethod for the aromatization of the ring A to produce steroid 3-ketal, respectively, with a peracid.
    [Show full text]
  • Clinical, Morphological and Biochemical Studies of a Virilizing Tumor in the Testis
    CLINICAL, MORPHOLOGICAL AND BIOCHEMICAL STUDIES OF A VIRILIZING TUMOR IN THE TESTIS Kenneth Savard, … , Edwin C. Hamblen, Frank L. Engel J Clin Invest. 1960;39(3):534-553. https://doi.org/10.1172/JCI104067. Research Article Find the latest version: https://jci.me/104067/pdf CLINICAL, MORPHOLOGICAL AND BIOCHEMICAL STUDIES OF A VIRILIZING TUMOR IN THE TESTIS * By KENNETH SAVARD,t RALPH I. DORFMAN, BILLY BAGGETT,t LINDA L. FIELDING, LEWIS L. ENGEL,§ HARRY T. McPHERSON, LEONARD M. LISTER,II DAVID S. JOHNSONA EDWIN C. HAMBLEN AND FRANK L. ENGEL (IProm the Worcester Foundation for Experimental Biology, Shrewsbury, Mass.; The John Collins Warren Laboratories, Collis P. Huntington Memorial Hospital of Harvard Uni- versity at Massachusetts General Hospital, and the Department of Biological Chem- istry, Harvard Medical School, Boston, Mass.; and the Departments of Medicine, Obstetrics and Gynecology, and Pathology, Division of Endocrinology, Duke University Medical Center, Durham, N. C.) (Submitted for publication May 18, 1959; accepted November 12, 1959) Although there is considerable indirect evidence such tumors cause elevated levels of urinary 17- indicating that virilizing testicular tumors exert ketosteroids. The morphology of these tumors their effects by producing androgenic steroid hor- leads one to predict that they are producing tes- mones, few attempts have been made to determine tosterone, since normal interstitial cells seem to the exact nature of the compounds produced. One have this function (22, 23). A few studies of the type of tumor which exerts particularly marked qualitative nature of the urinary steroids in pa- virilizing effects when found in prepubertal boys tients with this type of tumor seem to confirm such is that classified as an interstitial cell tumor of the a conclusion (13, 24).
    [Show full text]
  • Recent Steroid Findings in “Designer Supplements”
    In: W Schänzer, H Geyer, A Gotzmann, U Mareck (eds.) Recent Advances In Doping Analysis (17). Sport und Buch Strauß - Köln 2009 M.K. Parr1), N. Haenelt1), G. Fußhöller1), U. Flenker1), H. Geyer1), G. Rodchenkov2), G. Opfermann1), W. Schänzer1) Recent steroid findings in “Designer Supplements” 1)Institute of Biochemistry, German Sport University, Cologne, Germany 2)Antidoping Centre Moscow, Moscow, Russia Abstract Several supplements have been purchased from two different internet-based suppliers and were analysed for their steroid content. Besides the findings of DHEA (and DHEA esters) products were found to contain 6-bromoandrostenedione, androstanoisoxazoles, and estra-4,9- diene-3,17-dione. Additionally Δ6-methyltestosterone was detected in the product “Jungle Warfare” from ALR Industries, androst-4-ene-3,11,17-trione in the product “11Oxo” from Ergopharm, and finally the product “Oxyguno” distributed by Spectra Force Research was found to contain 4-chloro- 11-oxomethyltestosterone. These three compounds have been reported in the 1960s to show weak androgenic (about ½ of testosterone) and from weak to strong anabolic properties. The urinary metabolism was studied following the administration of one capsule to one test person each. The administration of Δ6-methyltestosterone was detectable for more than one week by monitoring the metabolites 17α-hydroxy-17β-methylandrosta-4,6-dien-3-one, 17α-methyl-5β- androstane-3α,17β-diol, and 17β-methyl-5β-androstane-3α,17α-diol. Oral administration of androst-4-ene-3,11,17-trione resulted in several reduced metabolites with 11β- hydroxyandrosterone as main product. Isotope ratio mass spectrometry confirmed the exogenous origin of 11β-hydroxyandrosterone and 11β-hydroxyetiocholanolone as well as their 11-oxo precursors for up to 24 hours.
    [Show full text]
  • Biological Efficacy and Plasma Norethisterone Levels of Orally Administered Norethisterone Enanthate in Rat and Hamster
    Indian J Physiol Pharmacol 1998; 42 (4) : 485-490 BIOLOGICAL EFFICACY AND PLASMA NORETHISTERONE LEVELS OF ORALLY ADMINISTERED NORETHISTERONE ENANTHATE IN RAT AND HAMSTER P. RAVINDER, K. MADHAVAN NAIR AND B. SIVAKUMAR* Division of Biophysics. National Institute of Nutrition. (Indian Council of Medical Research) Jamai-Osmania, Hyderabad - 500 007 (Received on September 11, 1997) Abstract: Norethisterone enanthate (NET-En) is a well known intramuscular contraceptive drug. The long acting nature of this prep~ration when administered orally was evalu~ted in female rats and hamsters using fertility inhibition test and from the plasma levels of norethisterone (NET). An oral dose of 20-60 mg NET-En was administered to random groups of six female rats and hamsters and were mated after five and ten days with males of proven fertility. The fertility inhibition rate was determined from vaginal delivery. A dose-dependent reduction in fertility was seen in rats 5 days after oral administration of NET-En. This effect was found to be less pronounced and not significant 10 days after administration of similar doses of NET-En. In hamsters, a similar but less pronounced effect was noted. The decrease in fertility was significant only at the 60 mg dose. The plasma levels of NET estimated by RIA over a period of 15 days, in a different set of treated rats, suggested rapid absorption of NET-En within a day, and drug concentration decreased slowly, the levels on the 4th day ranged from 0.9-2.3 with the 10 mg and 1.0-4.0 ng/ml with the 20 mg dose.
    [Show full text]
  • Sports Drug Testing and Toxicology TOP ARTICLES SUPPLEMENT
    Powered by Sports drug testing and toxicology TOP ARTICLES SUPPLEMENT CONTENTS REVIEW: Applications and challenges in using LC–MS/MS assays for quantitative doping analysis Bioanalysis Vol. 8 Issue 12 REVIEW: Current status and recent advantages in derivatization procedures in human doping control Bioanalysis Vol. 7 Issue 19 REVIEW: Advances in the detection of designer steroids in anti-doping Bioanalysis Vol. 6 Issue 6 Review For reprint orders, please contact [email protected] 8 Review 2016/05/28 Applications and challenges in using LC–MS/MS assays for quantitative doping analysis Bioanalysis LC–MS/MS is useful for qualitative and quantitative analysis of ‘doped’ biological Zhanliang Wang‡,1, samples from athletes. LC–MS/MS-based assays at low-mass resolution allow fast Jianghai Lu*,‡,2, and sensitive screening and quantification of targeted analytes that are based on Yinong Zhang1, Ye Tian2, 2 ,2 preselected diagnostic precursor–product ion pairs. Whereas LC coupled with high- Hong Yuan & Youxuan Xu** 1Food & Drug Anti-doping Laboratory, resolution/high-accuracy MS can be used for identification and quantification, both China Anti-Doping Agency, 1st Anding have advantages and challenges for routine analysis. Here, we review the literature Road, ChaoYang District, Beijing 100029, regarding various quantification methods for measuring prohibited substances in PR China athletes as they pertain to World Anti-Doping Agency regulations. 2National Anti-doping Laboratory, China Anti-Doping Agency, 1st Anding Road, First draft submitted:
    [Show full text]
  • Microbial Transformation of Bile Acids. a Unified Scheme for Bile Acid Degradation and Hydroxylation of Bile Acids
    SR P T03 Form 3 CONDITIONAL THE UNIVERSITY OF NEW SOUTH WALES DECLARATION RELATING TO DISPOSITION OF PROJECT REPORT/THESIS This is to certify that I d?..^ ...being a candidate for the degree of am fully aware of the policy of the University relating to the retention and use of higher degree project reports and theses, namely that the University retains the copies submitted for examination and is free to allow them to be consulted or borrowed. Subject to the provisions of the Copyright Act, 1968, the University may issue a project report or thesis in whole or in part, in photostat or microfilm or other copying medium. I wish the following condition to attach to the use of my project f^pert/thesis: . \ ^-ri pi^^fM-i oA ...-to. .m.P^^.E d .v ^y ^ Ci^^k ^ S.t 01- ^ ^sos-. ^ .TTlk^.f^ u QMIT^. ^L.J^ I also authorize the publication by University Microfilms of a 350 word abstract in Dissertation Abstracts International (applicable to doctorates only). Witness... ..e GENETIC MANIPULATION OF PSEUDOMONADS TO PRODUCE STEROID CATABOLITES FROM BILE ACIDS. A THESIS SUBMriTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF NEW SOUTH WALES AUSTRALIA BY JOHN ALTON IDE SCHOOL OF BIOTECHNOLOGY MAY, 1989. UNIVERSITY OF N.S.W. 16 MAY 1990 CONTENTS Page ABSTRACT i DECLARATION iii ACKNOWLEDGEMENTS iv LIST OF PUBLICATIONS v LIST OF TABLES vi LIST OF FIGURES viii ABBREVIATIONS xi 1 INTRODUCTION 1 LI INTRODUCTION TO STEROID PRODUCTION. 1 L2. EARLY SYNTHETIC PROCESSES FOR THE MANUFACTURE OF STEROID DRUGS. 4 L3. CURRENT PROCESSES 8 L4.
    [Show full text]
  • Epidemiology of Abnormal Uterine Bleeding 25 Michael Zinger 5
    Modern Management…Uterine Bleeding rev2:Modern Management…Uterine Bleeding rev2 9/1/08 10:24 Page 1 Modern Management of O’Donovan O’Donovan ABNORMAL • UTERINE BLEEDING Miller Modern Management of Modern Management of Abnormal Uterine Bleeding is written by an internationally recognized team of experts – many of whom are at the forefront of developing 'second-generation' endometrial ablation techniques as well as ABNORMAL UTERINE BLEEDING Modern Management of standard practice. The book covers the full range of surgical and medical treatments, including the background, diagnosis and treatment. ABNORMAL This must have book will help gynecologists refine their operative techniques and consider new approaches to this highly challenging condition. UTERINE BLEEDING Edited by Peter Joseph O`Donovan FRCOG FRCS (ENG) Consultant Gynaecologist and Gynaecological Cancer Lead Director MERIT Centre, Bradford Teaching Hospitals NHS Trust, Bradford and Professor of Medical Innovation, Bradford University, Bradford,UK Charles E Miller MD FACOG Director of Minimally Invasive Gynecologic Surgery, Lutheran General Hospital, Park Ridge, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Chicago, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA Cover illustration: ‘The Uterine’ by Elizabeth Gray © UK 2008 Edited by ISBN 978-0-415-45479-7 Peter Joseph O’Donovan www.informahealthcare.com 9 78041 5 454797 Charles Miller MODERN MANAGEMENT OF ABNORMAL
    [Show full text]
  • Tissue Steroid Levels in Response to Reduced Testicular Estrogen Synthesis in the Male Pig, Sus
    1 Tissue steroid levels in response to reduced testicular estrogen synthesis in the male pig, Sus 2 scrofa 3 Heidi Kucera1, Birgit Puschner1, Alan Conley2, Trish Berger3* 4 5 1 Department of Molecular Biosciences, School of Veterinary Medicine, University of California, 6 Davis, CA 7 2 Department of Population Health and Reproduction, School of Veterinary Medicine, University 8 of California, Davis, CA 9 3 Department of Animal Science, College of Agricultural and Environmental Sciences, 10 University of California, Davis, CA 11 12 Short title: Estrogen sulfates, aromatase activity and free estrogen concentrations in prostate, 13 testis and liver 14 15 * Corresponding author 16 E-mail: [email protected] (TB) 17 1 18 Abstract 19 Production of steroid hormones is complex and dependent upon steroidogenic enzymes, 20 cofactors, receptors, and transporters expressed within a tissue. Collectively, these factors create 21 an environment for tissue-specific steroid hormone profiles and potentially tissue-specific 22 responses to drug administration. Our objective was to assess steroid production, including 23 sulfated steroid metabolites in the boar testis, prostate, and liver following inhibition of 24 aromatase, the enzyme that converts androgen precursors to estrogens. Boars were treated with 25 the aromatase inhibitor, letrozole from 11 to 16 weeks of age and littermate boars received the 26 canola oil vehicle. Steroid profiles were evaluated in testes, prostate, and livers of 16, 20, and 40 27 week old boars using liquid chromatography/mass spectrometry. Testis, prostate, and liver had 28 unique steroid profiles in vehicle-treated animals. Only C18 steroid hormones were altered by 29 treatment with the aromatase inhibitor, letrozole; no significant differences were detected in any 30 of the C19 or C21 steroids evaluated.
    [Show full text]